Literature DB >> 20108077

Safety and efficacy of transcatheter closure of large patent ductus arteriosus in adults with a self-expandable occluder.

Man-Li Yu1, Xin-Miao Huang, Jia-Feng Wang, Yong-Wen Qin, Xian-Xian Zhao, Xing Zheng.   

Abstract

Most occurrences of large patent ductus arteriosus (PDAs) of > or =10 mm have been surgically closed, and transcatheter closure of these large PDAs was only reported in a few case reports. The present study reviewed our experience in transcatheter closure of such large PDAs with a Chinese self-expandable occluder, which is similar to but much cheaper than the Amplatzer occluder. From July 2000 to January 2008, 23 patients underwent transcatheter closure of large PDA > or =10 mm with this kind of occluder. The mean (SD) age of the patients was 38.0 (15.6) years (range 18-75 years). Radiographs of the chest, electrocardiograms, and echocardiograms were used for follow-up evaluation of the treatment within 1 day, 1 month, 6 months, and then every year after successful closure. The mean (SD) angiographic PDA diameter was 12.8 (2.6) mm (range 10-18 mm) and the mean occluder diameter was 18.0 (2.9) mm (range 16-22 mm). The occluders were delivered successfully and closed the PDA completely in 19 out of the 23 patients. Pulmonary arterial pressures decreased significantly after occlusion in patients with successful treatment: 67.3 (24.7) mmHg (range 29-122 mmHg) before occlusion and 42.3 (22.0) mmHg (range 19-98 mmHg) immediately after the procedure. Radiographs of the chest and echocardiograms showed that the diameters of the left atrium, left ventricle, and the main pulmonary artery decreased, and the ejection fraction (EF) increased at a mean (SD) follow-up of 36.3 (18.7) months (range 6-72 months). No severe complication occurred. The immediate and long-term outcomes suggested that transcatheter closure of PDAs with the native PDA occluder is a safe and effective treatment for adults with large PDA > or =10 mm.

Entities:  

Mesh:

Year:  2009        PMID: 20108077     DOI: 10.1007/s00380-009-1150-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  12 in total

Review 1.  Interventional treatment of patent ductus arteriosus in 2004.

Authors:  John W Moore; Daniel S Levi; Sarah D Moore; Douglas J Schneider; Farhouch Berdjis
Journal:  Catheter Cardiovasc Interv       Date:  2005-01       Impact factor: 2.692

2.  A noninvasive sizing method to choose fitted Amplatzer septal occluder by transthoracic echocardiography in patients with secundum atrial septal defects.

Authors:  Kuang-Jen Chien; Cheng-Liang Lee; Ta-Cheng Huang; Chu-Chuan Lin; Ken-Pen Weng; Shih-Hui Huang; Kai-Sheng Hsieh
Journal:  Heart Vessels       Date:  2007-07-20       Impact factor: 2.037

3.  Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results.

Authors:  J Masura; K P Walsh; B Thanopoulous; C Chan; J Bass; Y Goussous; P Gavora; Z M Hijazi
Journal:  J Am Coll Cardiol       Date:  1998-03-15       Impact factor: 24.094

4.  The Amplatzer duct occluder: experience in 209 patients.

Authors:  A A Bilkis; M Alwi; S Hasri; A L Haifa; K Geetha; M A Rehman; I Hasanah
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

5.  Challenges encountered during closure of patent ductus arteriosus.

Authors:  P Ewert
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

6.  Further experience with transcatheter closure of the patent ductus arteriosus using the Amplatzer duct occluder.

Authors:  B D Thanopoulos; F A Hakim; A Hiari; Y Goussous; E Basta; A A Zarayelyan; G S Tsaousis
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

7.  Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults.

Authors:  C Yan; S Zhao; S Jiang; Z Xu; L Huang; H Zheng; J Ling; C Wang; W Wu; H Hu; G Zhang; Z Ye; H Wang
Journal:  Heart       Date:  2006-09-05       Impact factor: 5.994

8.  Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results.

Authors:  Robert H Pass; Ziyad Hijazi; Daphne T Hsu; Veronica Lewis; William E Hellenbrand
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

9.  Transcatheter occlusion of the persistently patent ductus arteriosus. Forty-month follow-up and prevalence of residual shunting.

Authors:  M C Hosking; L N Benson; N Musewe; J D Dyck; R M Freedom
Journal:  Circulation       Date:  1991-12       Impact factor: 29.690

Review 10.  Forty-six years of patient ductus arteriosus division at Children's Memorial Hospital of Chicago. Standards for comparison.

Authors:  C Mavroudis; C L Backer; M Gevitz
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

View more
  11 in total

1.  Transcatheter closure of a large patent ductus arteriosus with severe pulmonary arterial hypertension in a child.

Authors:  C Karakurt; O Elkıran; S F Celik; G Koçak
Journal:  Herz       Date:  2013-07-18       Impact factor: 1.443

2.  Transcatheter closure of perimembranous ventricular septal defects (VSD) with VSD occluder: early and mid-term results.

Authors:  Yidong Wei; Xian Wang; Shouyan Zhang; Lei Hou; Yong Wang; Yawei Xu; Qi Sun; Huaibing Zhao
Journal:  Heart Vessels       Date:  2011-05-27       Impact factor: 2.037

3.  Successful percutaneous coil embolization of coronary-pulmonary, -carotid, and -internal mammary artery fistulas.

Authors:  Yohei Numasawa; Akio Kawamura; Subaru Hashimoto; Ayaka Endo; Shinsuke Yuasa; Yuichiro Maekawa; Sachio Kuribayashi; Keiichi Fukuda
Journal:  Heart Vessels       Date:  2011-07-07       Impact factor: 2.037

4.  Complications of cardiac catheterization in adults and children with congenital heart disease in the current era.

Authors:  Yoshiki Mori; Kazuhiro Takahashi; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2012-03-29       Impact factor: 2.037

5.  Long-term Results of Transcatheter Closure of Patent Ductus Arteriosus in Adolescents and Adults with Amplatzer Duct Occluder.

Authors:  Mostafa Behjati-Ardakani; Mansour Rafiei; Mohammad Amin Behjati-Ardakani; Mohammadreza Vafaeenasab; Mohammadtaghi Sarebanhassanabadi
Journal:  N Am J Med Sci       Date:  2015-05

6.  Experience with percutaneous closure of ductus arteriosus using the Amplatzer duct occluder in 243 consecutive patients and long-term results-A single centre study.

Authors:  Mostafa Behjati-Ardakani; Mohammad Amin Behjati-Ardakani; Mehdi Hadadzadeh; Seyed Hossein Moshtaghion; Mohammadtaghi Sarebanhassanabadi
Journal:  Niger Med J       Date:  2014-09

7.  Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure.

Authors:  Jianqi Feng; Xiangqing Kong; Yanhui Sheng; Rong Yang
Journal:  Ther Clin Risk Manag       Date:  2016-11-03       Impact factor: 2.423

8.  Large patent ductus arteriosus: To close or not to close.

Authors:  Jaganmohan Tharakan; Subramanian Venkateshwaran
Journal:  Ann Pediatr Cardiol       Date:  2012-07

9.  Percutaneous closure of patent arterial ducts in patients from high altitude: a sub-Saharan experience.

Authors:  Endale Tefera; Shakeel A Qureshi; Ramòn Bermudez-Cañete; Lola Rubio
Journal:  Ann Pediatr Cardiol       Date:  2015 Sep-Dec

10.  Contemporary outcomes of percutaneous closure of patent ductus arteriosus in adolescents and adults.

Authors:  Sudhakar P; John Jose; Oommen K George
Journal:  Indian Heart J       Date:  2017-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.